acne scar. Scar conditions and fibrosis of skin
Conditions
Interventions
Intervention 1: Intervention group: in one side of the face, subcision was done and after 2 weeks, the process of treatment was followed by three sessions of microneedle radiofrequency. There was a 4-
Treatment - Devices
Intervention group: in one side of the face, subcision was done and after 2 weeks, the process of treatment was followed by three sessions of microneedle radiofrequency. There was a 4-week interval be
Control group: the other side of the face received microneedle radiofrequency without subcision during three sessions. There was a 4-week interval between each two sessions.
Sponsors
Vice Chancellor for research of Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age = 18 year; patient suffering from polymorphic and mixed acne; the acne scars should be in both sides of the face; Fitzpatrick skin types 2 to 4; informed consent for participation in the study. Exclusion Criteria: patients who are suffering from hypertrophic or Keloid scars.
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Edema; Erythema; Pruritis; Hypo and Hyper pigmentation. Timepoint: After two weeks of each therapy session. Method of measurement: Patient self administered checklist of overall satisfaction.;Clinical improvement of atrophic scar. Timepoint: Baseline,three months after the last therapy session. Method of measurement: Serial photography and evaluation by two dermatologists blinded to the randomization process.;Patients satisfaction. Timepoint: Three months after the last therapy session. Method of measurement: Patient self administered checklist of overall satisfaction. | — |
Primary
| Measure | Time frame |
|---|---|
| Atrophic scar of acne. Timepoint: Baseline,three months after the last therapy session. Method of measurement: Serial photography and evaluation by two dermatologists blinded to the randomization process. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Nazila Poostiyan
Skin disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences,
Outcome results
None listed